Amy E. Armstrong

1.7k total citations
46 papers, 636 citations indexed

About

Amy E. Armstrong is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Amy E. Armstrong has authored 46 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Amy E. Armstrong's work include Neuroblastoma Research and Treatments (10 papers), Sarcoma Diagnosis and Treatment (8 papers) and Renal and related cancers (7 papers). Amy E. Armstrong is often cited by papers focused on Neuroblastoma Research and Treatments (10 papers), Sarcoma Diagnosis and Treatment (8 papers) and Renal and related cancers (7 papers). Amy E. Armstrong collaborates with scholars based in United States, Italy and Canada. Amy E. Armstrong's co-authors include Sonali Chaudhury, William J. Muller, Jenna Rossoff, John P. Fulkerson, Soyang Kwon, Sameer Patel, Desiree Hollemon, Eileen Gillan, David K. Hong and Angela C. Hirbe and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Amy E. Armstrong

42 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy E. Armstrong United States 12 188 140 137 126 103 46 636
Roberto Guaschino Italy 14 153 0.8× 74 0.5× 114 0.8× 53 0.4× 129 1.3× 26 711
Vincent Barlogis France 21 139 0.7× 146 1.0× 78 0.6× 36 0.3× 77 0.7× 53 1.3k
Lila Penchansky United States 15 354 1.9× 191 1.4× 131 1.0× 55 0.4× 111 1.1× 50 907
Anne–Marie Zagdanski France 16 160 0.9× 103 0.7× 92 0.7× 49 0.4× 193 1.9× 40 674
Soon‐Phaik Chee Singapore 26 379 2.0× 130 0.9× 112 0.8× 143 1.1× 199 1.9× 88 2.2k
Suna Erkılıç Türkiye 17 141 0.8× 103 0.7× 102 0.7× 19 0.2× 133 1.3× 55 638
M. Dandurand France 14 173 0.9× 126 0.9× 45 0.3× 89 0.7× 99 1.0× 48 664
Carmen G. Espinoza United States 18 130 0.7× 94 0.7× 127 0.9× 53 0.4× 99 1.0× 28 626
Gary Solomon United States 16 102 0.5× 55 0.4× 38 0.3× 56 0.4× 233 2.3× 33 900
Abdulaziz Al Khaldi Saudi Arabia 5 89 0.5× 157 1.1× 118 0.9× 108 0.9× 150 1.5× 8 939

Countries citing papers authored by Amy E. Armstrong

Since Specialization
Citations

This map shows the geographic impact of Amy E. Armstrong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Armstrong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Armstrong more than expected).

Fields of papers citing papers by Amy E. Armstrong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Armstrong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Armstrong. The network helps show where Amy E. Armstrong may publish in the future.

Co-authorship network of co-authors of Amy E. Armstrong

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Armstrong. A scholar is included among the top collaborators of Amy E. Armstrong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Armstrong. Amy E. Armstrong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Armstrong, Amy E., Najat C. Daw, Lindsay A. Renfro, et al.. (2025). Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies. Cancer. 131(2). e35713–e35713. 2 indexed citations
2.
Desai, Ami V., Amy E. Armstrong, Cornelis M. van Tilburg, et al.. (2025). Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions. European Journal of Cancer. 220. 115308–115308. 1 indexed citations
3.
Li, Jue, Jie Bai, Michihiro Hashimoto, et al.. (2025). Loss of Cpt1a results in elevated glucose-fueled mitochondrial oxidative phosphorylation and defective hematopoietic stem cells. Journal of Clinical Investigation. 135(5). 2 indexed citations
4.
Cluster, Andrew, Ali Mian, Sonika Dahiya, et al.. (2025). Collaborative frontiers in pediatric neuro-oncology: establishing an international tumor board for enhanced care and global impact. International Journal of Clinical Oncology. 30(8). 1659–1669.
5.
Armstrong, Amy E., et al.. (2025). Hypospadias: The lay of the land. Journal of Plastic Reconstructive & Aesthetic Surgery. 102. 145–148. 2 indexed citations
6.
Gupta, Ajay, Richard F. Riedel, Scott C. Borinstein, et al.. (2024). Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board. Cancer. 130(23). 4028–4039. 2 indexed citations
7.
Desai, Ami V., Giles Robinson, Yeming Wu, et al.. (2024). Efficacy and safety of entrectinib in children with extracranial solid or primary central nervous system (CNS) tumors harboring NTRK or ROS1 fusions.. Journal of Clinical Oncology. 42(16_suppl). 10000–10000. 1 indexed citations
8.
Ortiz, Michael V., Christa Koenig, Amy E. Armstrong, et al.. (2023). Advances in the clinical management of high‐risk Wilms tumors. Pediatric Blood & Cancer. 70(S2). e30342–e30342. 7 indexed citations
9.
Ortiz, Michael V., Christa Koenig, Amy E. Armstrong, et al.. (2023). Advances in the clinical management of high‐risk Wilms tumors. Pediatric Blood & Cancer. 70(3). 8 indexed citations
10.
Armstrong, Amy E., Allan J. Belzberg, John R. Crawford, Angela C. Hirbe, & Zhihong J. Wang. (2023). Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas. BMC Cancer. 23(1). 553–553. 30 indexed citations
11.
12.
Armstrong, Amy E., Najat C. Daw, Lindsay A. Renfro, et al.. (2023). Treatment of focal anaplastic Wilms tumor (FAWT): A report from the Children’s Oncology Group (COG) AREN0321 and AREN03B2 studies.. Journal of Clinical Oncology. 41(16_suppl). 10005–10005.
13.
Nieblas‐Bedolla, Edwin, et al.. (2022). A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses. Pediatric Neurology. 134. 1–6. 2 indexed citations
14.
Armstrong, Amy E., et al.. (2020). Neurofibromatosis type 1-related tumours in paediatrics: an evolving treatment landscape. The Lancet Child & Adolescent Health. 4(7). 488–490. 3 indexed citations
15.
Armstrong, Amy E., et al.. (2020). Cutaneous reactions to pediatric cancer treatment: Part I. Conventional chemotherapy. Pediatric Dermatology. 38(1). 8–17. 4 indexed citations
16.
Armstrong, Amy E., Jenna Rossoff, Desiree Hollemon, et al.. (2019). Cell‐free DNA next‐generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease. Pediatric Blood & Cancer. 66(7). e27734–e27734. 73 indexed citations
17.
Armstrong, Amy E., Samantha Gadd, Vicki Huff, et al.. (2018). A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children’s Oncology Group study. PLoS ONE. 13(12). e0208936–e0208936. 30 indexed citations
18.
19.
Armstrong, Amy E., et al.. (2012). Anatomic Guidelines for Harvesting a Quadriceps Free Tendon Autograft for Anterior Cruciate Ligament Reconstruction. Arthroscopy The Journal of Arthroscopic and Related Surgery. 28(7). 980–984. 66 indexed citations
20.
Saccoccio, Frances M., Anne Sauer, Amy E. Armstrong, et al.. (2011). Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells. Vaccine. 29(15). 2705–2711. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Guaschino Breakdown of academic impact, for papers by Vincent Barlogis Breakdown of academic impact, for papers by Lila Penchansky Breakdown of academic impact, for papers by Anne–Marie Zagdanski Breakdown of academic impact, for papers by Soon‐Phaik Chee Breakdown of academic impact, for papers by Suna Erkılıç Breakdown of academic impact, for papers by M. Dandurand Breakdown of academic impact, for papers by Carmen G. Espinoza Breakdown of academic impact, for papers by Gary Solomon Breakdown of academic impact, for papers by Abdulaziz Al Khaldi
Rankless by CCL
2026